ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
ACHIEVE LIFE SCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.61+0.23 (+3.53%)
Close on Oct 19, 2026
- Market cap
- $617.64M
- P/E (TTM)
- –
- Dividend yield
- –